Article
A co-formulation of Interferons alpha2b and gamma distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG
2022-12-20
Abstract excerpt
<title>Abstract</title><p><bold>Background</bold>HeberFERON is a co-formulation of α2b and γ interferons, based on their synergism, which has shown its clinical superiority over individual interferons in basal cell carcinomas. In glioblastoma (GBM), HeberFERON has displayed promising preclinical and clinical results. This led us to design a microarray experiment aimed at identifying the molecular mechanisms involv...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e2fde8b2-1c4a-5400-a6ca-f5064fdd4769
- DOI
- 10.21203/rs.3.rs-2369826/v1
